SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $33,000 | +3.1% | 60,215 | +2.2% | 0.00% | – |
| Q1 2016 | $32,000 | -44.8% | 58,932 | -8.2% | 0.00% | – |
| Q4 2015 | $58,000 | +20.8% | 64,185 | +8.9% | 0.00% | – |
| Q3 2015 | $48,000 | -72.9% | 58,932 | -0.0% | 0.00% | – |
| Q2 2015 | $177,000 | -65.8% | 58,941 | -72.1% | 0.00% | – |
| Q1 2015 | $518,000 | -4.4% | 211,584 | -0.4% | 0.00% | – |
| Q4 2014 | $542,000 | -77.6% | 212,378 | -37.3% | 0.00% | -100.0% |
| Q3 2014 | $2,419,000 | -28.7% | 338,760 | -34.9% | 0.00% | – |
| Q2 2014 | $3,392,000 | +199.9% | 520,260 | +204.0% | 0.00% | – |
| Q1 2014 | $1,131,000 | +41.2% | 171,137 | +1.2% | 0.00% | – |
| Q4 2013 | $801,000 | -52.4% | 169,124 | -50.2% | 0.00% | – |
| Q3 2013 | $1,684,000 | -75.3% | 339,658 | -74.2% | 0.00% | -100.0% |
| Q2 2013 | $6,829,000 | – | 1,316,966 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |